APEX1 and central nervous system cancer: Also, it has been previously shown that the antisense oligonucleotides used in the present paper are able to reduce APE/ref-1 protein and endonuclease activity in human glioma cells, with concurrent reduction in resistance towards the alkylating agents methyl methanesulphonate and temozolomide (Silber et al, 2002).